Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7376 p635
19 November 2005

This article
Reprint   Photocopy

PDF 100K, Acrobat Reader

Letters

· The Guild (2)
· Gender
· Prescriptions
· Medicines use reviews (3)
· Supervision (2)
· Skin cancer
· North East London LPC
· Birdsgrove House
· The Society (2)


Letters to the Editor

Birdsgrove House

Visit arouses questions

From Mrs M. P. Stainton, MRPharmS

Recently my husband and I were in Derbyshire. On our return journey we parked outside Birdsgrove House and went to look at what I still consider to be the property of the members. Having identified ourselves we were given supervised access to the ground floor by one of the security guards.

This visit raised a number of concerns, which may be of interest to other members of the Royal Pharmaceutical Society. Why are all the treasures still in the house and not in secure storage? We noticed several pieces of valuable furniture which had been donated, including a beautiful polished wooden dresser given by the Hounslow branch and a long case clock donated in the 1970s by a member of the Society. The security firm has a 12-month contract for 24-hour-a-day surveillance including CCTV (which had yet to be fitted). The grounds are also being maintained and local taxes will have to be paid. Why is the house not being used for the benefit of Society members until a buyer is found? Surely it would sell better as a going concern. How much is it going to cost to maintain until it is sold? Will the many gifts which have been donated over the years be returned to the donors or their next of kin? How long will this take and how much will it cost?

Members need to know about these matters. Also it would have been good for members to be given a final opportunity to experience the peace and tranquillity of a stay at Birdsgrove before it is finally lost to us forever.

Marie Stainton
Sandy, Bedfordshire

 

BERNARD KELLY, director of finance and resources at the Royal Pharmaceutical Society, responds:

Birdsgrove House and its contents belong to the Benevolent Funds of the Royal Pharmaceutical Society of Great Britain. The Benevolent Fund is a registered charity and the members of the Society’s Council act as trustees of the charity.

The house was officially closed on Friday 30 September. The decision to close the house was communicated to members through the pages of the PJ on 20 August (p215).

Before the closure, a 12-month contract was agreed with a local security company: 24-hour-a-day security was started in early September and CCTV was installed on 2 October. The alarm system for the house was upgraded on closure and is linked automatically to both the offices of the security company and the local police. This level of security will ensure that the building and its contents are fully protected.

An inventory of the house was made before closure and all assets have been photographed, tagged and valued. A number of local and national auctioneers have been invited to tender for the opportunity to auction the contents of the house. Once an auction house has been selected, the contents will be transferred to their premises before auction. Moving the contents to a separate secure facility in the interim would add considerably to costs. Maintaining this level of security is a fraction of the running costs previously being incurred.

Where possible, donors of items to the house are being consulted on the future of the donation and, at their October meeting, branch and regional secretaries were asked to assist by consulting their members on this issue. The auction of items will be delayed until this consultation is completed.

The eventual sale of Birdsgrove House could take up to a year as this is a large property and achieving the best value will require careful assessment of the options available and appropriate marketing. Sale cannot go ahead until the agreement of the Charity Commission has been obtained.

Send your letter to The Editor

Previous Topic (North East London LPC)
Next Topic (The Society)

Back to Top


©The Pharmaceutical Journal